about
The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersMicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaMicroRNA expression profiles in the management of papillary thyroid cancer.The Covidien LigaSure Maryland Jaw Device.Epigenetic regulation of RET receptor tyrosine kinase and non-coding RNAs in MTC.Incidence and Risk Factors for Occult Level 3 Lymph Node Metastases in Papillary Thyroid Cancer.MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.Thermal sealing systems with and without tissue divider for total thyroidectomy.The Weight of the Resected Gland Predicts Rate of Success After Image-Guided Focused Parathyroidectomy.Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluation.Impact of the American Thyroid Association guidelines on the Australian surgical management of papillary thyroid cancerEditorial - Endocrine Tumor.Improving Outcomes in Adrenocortical Cancer: An Australian PerspectiveUse of the Nerve Integrity Monitor during Thyroid Surgery Aids Identification of the External Branch of the Superior Laryngeal NerveLong noncoding RNA profiles of adrenocortical cancer can be used to predict recurrenceSclerosing mesenteritis: a diagnosis worth consideringOutcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasisProspective evaluation of the utility of routine neuromonitoring for an established thyroid surgical practiceTreatment and management of adrenal cancer in a specialized Australian endocrine surgical unit: approaches, outcomes and lessons learntBest practice for the management of pediatric thyroid cancerRisk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomymicroRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical CarcinomaUtility of the American College of Surgeons National Surgical Quality Improvement Program surgical risk calculator in predicting mortality in an Australian acute surgical unit
P50
Q33973108-2F5F667D-D86A-4D60-96A1-8288CB05DFCBQ35151124-DEF757D2-B4B6-4F34-819C-DC779B7591A5Q36546760-C77101C4-0501-454C-AD48-49905BD50025Q38260896-9BCB92A7-AC3C-4879-9C03-78FECA2504B8Q38272290-E3EFDA0A-2275-48A9-B7E4-AAEB631A7F01Q39185812-B9E4EDFE-699B-4729-9EC6-75B69773A247Q39759641-5A914E95-3F56-4CE4-BD0A-CC35AF6B6C67Q44934849-61EC895B-C9E9-490F-844B-1F5E74147B83Q46213432-AD91C4EF-6B75-4782-8ADA-C32D87709005Q47405947-01D8D858-9CF6-452A-8546-5028D594739BQ53090391-BA21EB18-8CF0-476A-91C3-43E92F14C74EQ58542733-5BE8B090-6513-4BF6-962D-66BBED469064Q64976530-779308CF-4ED2-476C-A9EC-060301337E7DQ85801143-74F61A27-2383-4A64-8556-37E7AF6B6800Q85801154-0876A8A8-AE51-48B4-AC18-2F5F13198E67Q86546846-7CDF08D2-44B5-4085-9BF0-AD58FDC7BCE5Q86612077-9EAAFB8F-C260-42D9-BCE3-8BD111E1A716Q87725428-1A3FFC0A-E3F8-44BD-9D14-8FEE99E6F7BDQ89250634-15D92644-2419-4FFB-B652-D763FD5C1C06Q91313768-0AE7C58A-1941-4C5A-BD40-A381331DA569Q91459202-AF308FF9-4242-43F8-8542-E1C4204F71B9Q92647283-80A0EEB2-1D5B-4CE0-9DDC-B56C5A965852Q92657881-9C31915D-3510-46D0-BDAE-9536BDBA3EFBQ94456915-A991C9A7-D6E6-4BF0-99E3-A0686265025F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anthony R Glover
@ast
Anthony R Glover
@en
Anthony R Glover
@es
Anthony R Glover
@nl
type
label
Anthony R Glover
@ast
Anthony R Glover
@en
Anthony R Glover
@es
Anthony R Glover
@nl
prefLabel
Anthony R Glover
@ast
Anthony R Glover
@en
Anthony R Glover
@es
Anthony R Glover
@nl
P106
P31
P496
0000-0003-0762-0977